1154 related articles for article (PubMed ID: 32151446)
1. [Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?].
Frajerman A; Kebir O; Chaumette B; Tessier C; Lamazière A; Nuss P; Krebs MO
Encephale; 2020 Jun; 46(3):209-216. PubMed ID: 32151446
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms.
Hsu MC; Huang YS; Ouyang WC
Lipids Health Dis; 2020 Jul; 19(1):159. PubMed ID: 32620164
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.
Smesny S; Milleit B; Hipler UC; Milleit C; Schäfer MR; Klier CM; Holub M; Holzer I; Berger GE; Otto M; Nenadic I; Berk M; McGorry PD; Sauer H; Amminger GP
Mol Psychiatry; 2014 Mar; 19(3):317-24. PubMed ID: 23478748
[TBL] [Abstract][Full Text] [Related]
4. Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations.
Tessier C; Sweers K; Frajerman A; Bergaoui H; Ferreri F; Delva C; Lapidus N; Lamaziere A; Roiser JP; De Hert M; Nuss P
Transl Psychiatry; 2016 Oct; 6(10):e906. PubMed ID: 27701405
[TBL] [Abstract][Full Text] [Related]
5. [Lipids, depression and suicide].
Colin A; Reggers J; Castronovo V; Ansseau M
Encephale; 2003; 29(1):49-58. PubMed ID: 12640327
[TBL] [Abstract][Full Text] [Related]
6. Differences in omega-3 and omega-6 polyunsaturated fatty acid consumption in people at ultra-high risk of psychosis, first-episode schizophrenia, and in healthy controls.
Pawełczyk T; Trafalska E; Pawełczyk A; Kotlicka-Antczak M
Early Interv Psychiatry; 2017 Dec; 11(6):498-508. PubMed ID: 26279283
[TBL] [Abstract][Full Text] [Related]
7. Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis.
Alqarni A; Mitchell TW; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Berger M; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Meyer BJ; Amminger GP
Schizophr Res; 2020 Dec; 226():52-60. PubMed ID: 31606244
[TBL] [Abstract][Full Text] [Related]
8. Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.
Smesny S; Milleit B; Schaefer MR; Hesse J; Schlögelhofer M; Langbein K; Hipler UC; Berger M; Cotter DR; Sauer H; McGorry PD; Amminger GP
Schizophr Res; 2017 Oct; 188():110-117. PubMed ID: 28126360
[TBL] [Abstract][Full Text] [Related]
9. Polyunsaturated fatty acid concentration predicts myelin integrity in early-phase psychosis.
Peters BD; Machielsen MW; Hoen WP; Caan MW; Malhotra AK; Szeszko PR; Duran M; Olabarriaga SD; de Haan L
Schizophr Bull; 2013 Jul; 39(4):830-8. PubMed ID: 22927668
[TBL] [Abstract][Full Text] [Related]
10. Shared Biological Pathways between Antipsychotics and Omega-3 Fatty Acids: A Key Feature for Schizophrenia Preventive Treatment?
Frajerman A; Scoriels L; Kebir O; Chaumette B
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206945
[TBL] [Abstract][Full Text] [Related]
11. A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol.
Qurashi I; Chaudhry IB; Khoso AB; Farooque S; Lane S; Husain MO; Chu S; Sarginson J; Hamarani M; Naqvi HA; Razzaque B; Minhas FA; Yung AR; Deakin JFW; Husain N
Trials; 2017 Nov; 18(1):524. PubMed ID: 29121974
[TBL] [Abstract][Full Text] [Related]
12. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia.
Fenton WS; Hibbeln J; Knable M
Biol Psychiatry; 2000 Jan; 47(1):8-21. PubMed ID: 10650444
[TBL] [Abstract][Full Text] [Related]
13. Membrane Lipids in Ultra-High-Risk Patients: Potential Predictive Biomarkers of Conversion to Psychosis.
Frajerman A; Chaumette B; Farabos D; Despres G; Simonard C; Lamazière A; Krebs MO; Kebir O
Nutrients; 2023 May; 15(9):. PubMed ID: 37432345
[TBL] [Abstract][Full Text] [Related]
14. Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people.
Alqarni A; Mitchell TW; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Berger M; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Amminger GP; Meyer BJ
Schizophr Res; 2020 Dec; 226():44-51. PubMed ID: 31301881
[TBL] [Abstract][Full Text] [Related]
15. [Stress and psychotic transition: A literature review].
Chaumette B; Kebir O; Mam Lam Fook C; Bourgin J; Godsil BP; Gaillard R; Jay TM; Krebs MO
Encephale; 2016 Aug; 42(4):367-73. PubMed ID: 27161263
[TBL] [Abstract][Full Text] [Related]
16. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
[TBL] [Abstract][Full Text] [Related]
17. White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids.
Vijayakumar N; Bartholomeusz C; Whitford T; Hermens DF; Nelson B; Rice S; Whittle S; Pantelis C; McGorry P; Schäfer MR; Amminger GP
BMC Psychiatry; 2016 Aug; 16(1):287. PubMed ID: 27515430
[TBL] [Abstract][Full Text] [Related]
18. [Lipids and mental disorders: Evidence, uncertainties and perspectives].
Theodoropoulou S; Gialouris AG
Psychiatriki; 2019; 30(2):129-141. PubMed ID: 31425141
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Review of Effectiveness of Omega-3 Fatty Acid Supplementation on Symptoms, Social Functions, and Neurobiological Variables in Schizophrenia.
Hsu MC; Ouyang WC
Biol Res Nurs; 2021 Oct; 23(4):723-737. PubMed ID: 34281415
[TBL] [Abstract][Full Text] [Related]
20. Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis.
Berger GE; Smesny S; Schäfer MR; Milleit B; Langbein K; Hipler UC; Milleit C; Klier CM; Schlögelhofer M; Holub M; Holzer I; Berk M; McGorry PD; Sauer H; Amminger GP
PLoS One; 2016; 11(2):e0148429. PubMed ID: 26894921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
